相关实验视频
Updated: Sep 18, 2025

05:57
Fat Preference: A Novel Model of Eating Behavior in Rats
Published on: June 27, 2014
13.3K
多组学分析揭示了饮食偏好与NAFLD风险之间的因果关系和潜在调解者
Qingan Fu1,2, Jierui Liu3, Zhekang Liu4
1Department of Endocrinology and Metabolism, the Second Affiliated Hospital, Jiangxi Medical College Nanchang University Nanchang China.
Food science & nutrition
|June 24, 2025
概括
低热量饮食可以通过调节DNER来降低非酒精性脂肪性肝病 (NAFLD) 的风险. 特定的基因变异将软奶酪和果汁摄入与NAFLD联系起来,突出了预防个性化的营养.
科学领域:
- 遗传学和营养学
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一个日益严重的全球健康问题,与肥胖和代谢综合征密切相关.
- 了解饮食习惯和NAFLD病原体之间的相互作用对于有效的预防和治疗策略至关重要.
研究的目的:
- 使用多学科方法调查饮食偏好与NAFLD风险之间的因果关系.
- 确定调解因素和连接饮食和NAFLD的潜在分子机制.
- 探索FTO和DNER作为NAFLD的潜在治疗点.
主要方法:
- 全基因组关联研究 (GWAS) 以确定遗传关联.
- 两个步骤的门德尔随机化 (MR) 分析来评估因果关系和炎症调解.
- 同定位分析以确定因果基因定位点.
- 使用国家健康和营养检查调查 (NHANES) 临床数据和生物信息学进行验证.
主要成果:
- 发现偏好低热量饮食可以通过DNER调节显著降低NAFLD风险.
- 确定了FTO基因变异rs28429148作为软奶酪/果汁摄入量与NAFLD风险之间的关键调解者.
- 软奶酪消费与NAFLD风险增加有关,而果汁摄入与风险降低有关.
结论:
- 这项研究提供了第一个全面的多学科阐明饮食偏好对NAFLD风险的因果关系.
- 确定FTO和DNER是饮食与NAFLD关系中的重要参与者,提供潜在的治疗途径.
- 强调个性化饮食干预措施对于NAFLD预防和临床管理的重要性.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42

